Found 4 matching trials
Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years)
PHASE3This study is designed to evaluate the immunogenicity and safety of GSK Bio...
Location
GSK Investigational Site
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US
PHASE3This phase 3b study is designed to assess the safety of GlaxoSmithKline Bio...
Location
GSK Investigational Site
Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study
PHASE3This phase IIIb study is designed to assess the safety of GlaxoSmithKline B...
Location
GSK Investigational Site
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand
PHASE3This phase 3b study is designed to assess the safety of GlaxoSmithKline Bio...
Location
GSK Investigational Site